Clinical Trials on Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass in Australia

Total 8 results

Fresenius Kabi

Completed

Voluven® in Paediatric Patients

Cardiac Surgery | Cardiopulmonary Bypass

Austria, Belgium
Austin Health

Completed

Sodium Bicarbonate in Cardiac Surgery

Cardiac Surgery and Cardiopulmonary Bypass

Australia
Austin Health

Completed

High-Dose N-Acetylcysteine in Cardiac Surgery

Cardiac Surgery and Cardiopulmonary Bypass

Australia
Austin Health

Terminated

Sodium Bicarbonate in Cardiac Surgery Study (Bic-MC)

Cardiac Surgery | Cardiopulmonary Bypass

Canada, Australia, Germany, Ireland
Bayside Health
Griffith University

Completed

Preparation of Patients for Cardiac Surgery (MPM)

Coronary Artery Bypass Graft Surgery | Cardiac Valve Surgery

Australia
Bayside Health
Australian and New Zealand College of Anaesthetists

Completed

Limiting IV Chloride to Reduce AKI After Cardiac Surgery (LICRA)

Patients Undergoing Cardiothoracic Surgery

Australia
Novo Nordisk A/S

Completed

Activated Recombinant Human Factor VII Following Cardiac Bypass Surgery for Paediatric Congenital Heart Disease

Acquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary Bypass

Australia
Alexion Pharmaceuticals, Inc.

Recruiting

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE (ARTEMIS)

Chronic Kidney Disease | CKD | Cardiopulmonary Bypass | Cardiac Disease

United States, China, Germany, Italy, Korea, Republic of, Spain, Japan, Brazil, India, Taiwan, Australia, Israel, Hong Kong, United Kingdom, Poland, Argentina, Canada, Turkey, Netherlands

Clinical Trials on Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations